ESR1 and breast cancer: The human breast cancer cell line MCF7 was originally thought to be a monoclonal cell line but were recently discovered as populations of breast cancer cells with high levels of molecular heterogeneity (but mostly ER+, wild-type p53+, estrogen-dependent, and tamoxifen-sensitive) (Leung et al., 2010, 2014).